Cargando…
Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
[Image: see text] In an endeavor to identify small molecules for the management of non-small-cell lung carcinoma, 10 new hydrazone derivatives (3a–j) were synthesized. MTT test was conducted to examine their cytotoxic activities against human lung adenocarcinoma (A549) and mouse embryonic fibroblast...
Autores principales: | Erdönmez, Burak, Altıntop, Mehlika Dilek, Akalın Çiftçi, Gülşen, Özdemir, Ahmet, Ece, Abdulilah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249096/ https://www.ncbi.nlm.nih.gov/pubmed/37305321 http://dx.doi.org/10.1021/acsomega.3c02331 |
Ejemplares similares
-
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2018) -
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2023) -
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy
por: Özdemir, Ahmet, et al.
Publicado: (2022) -
Design, Synthesis,
and Evaluation of a New Series
of 2-Pyrazolines as Potential Antileukemic Agents
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2023) -
Synthesis and in Vitro Evaluation of New Nitro-Substituted Thiazolyl Hydrazone Derivatives as Anticandidal and Anticancer Agents
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2014)